0.000USD0.000Pre-market 08/03, 09:30 (ET)
580.66MMarket Cap
LossP/E TTM
Key Figures
8.610Open
8.720High
1.59MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
3.00%Turnover Ratio
8.550Prev. Close
8.210Low
10.01MTurnover
LossP/E Static
5.23P/B
0.00%Div Yield TTM
-60.47%ROA
11.61052wk High
1.00Volume Ratio
-21.61MNet Profit
53.01MShares
-0.9222EPS TTM
0.10Beta
-74.47%ROE
1.87052wk Low
5.96%Amplitude
--Gross Margin
580.66MMarket Cap
-3.32Reward/Risk
5.48%Risk Rate
Immix Biopharma Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Immix Biopharma Inc Info
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the application of chimeric antigen receptor cell therapy (CAR- T) in light chain (AL) Amyloidosis and select immune-mediated diseases. The Company's lead cell therapy candidate CAR-T NXC-201 (NXC-201), which is being evaluated in its ongoing United States Phase Ib/II NEXICART-2 (NCT06097832) clinical trial. Its lead program, NXC-201 is a next generation CAR-T targeting B-cell maturation antigen. CAR-T cell therapy is a type of immunotherapy that uses the patient’s own immune cells, modified with its proprietary technology. Its N-GENIUS cell engineering platform with EXPAND technology has produced clinical-stage CAR-T NXC-201, targeting B cell maturation antigen, which is autologous CAR-T being developed to treat AL Amyloidosis.
Ticker SymbolIMMX
CompanyImmix Biopharma Inc
CEORachman (Ilya)
Websitehttps://immixbio.com/
Shareholders
FAQs
What is the current price of Immix Biopharma Inc (IMMX)?
The current price of Immix Biopharma Inc (IMMX) is 8.32.
What is the symbol of Immix Biopharma Inc?
The ticker symbol of Immix Biopharma Inc is IMMX.
What is the 52-week high of Immix Biopharma Inc?
The 52-week high of Immix Biopharma Inc is 11.61.
What is the 52-week low of Immix Biopharma Inc?
The 52-week low of Immix Biopharma Inc is 1.87.
What is the market capitalization of Immix Biopharma Inc?
The market capitalization of Immix Biopharma Inc is 580.66M.
Is Immix Biopharma Inc (IMMX) currently rated as Buy, Hold, or Sell?
According to analysts, Immix Biopharma Inc (IMMX) has an overall rating of Buy, with a price target of 20.71.
What is the Earnings Per Share (EPS TTM) of Immix Biopharma Inc (IMMX)?
The Earnings Per Share (EPS TTM) of Immix Biopharma Inc (IMMX) is -0.89.
